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Cationic Gemini Surfactants Based on Tartaric Acid: Synthesis, Aggregation,
Monolayer Behaviour, and Interaction with DNA
Petrus J. J. A. Buijnsters,[a][‡] Cristina L. Garcı´a Rodrı´guez,[a][‡‡] Egon L. Willighagen,[a]
Nico A. J. M. Sommerdijk,[a][‡‡‡] Andreas Kremer,[b][‡‡‡‡] Patrick Camilleri,[b]
Martinus C. Feiters,*[a] Roeland J. M. Nolte,[a] and Binne Zwanenburg[a]
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The synthesis of three novel cationic gemini surfactants (10,
12, and 14) based on tartaric acid appended with biocompat-
ible palmitoyl tails and head groups is described, and their
aggregation in water, monolayer behaviour, DNA binding,
and gene transfection activities are reported. The monolayer
studies showed that the molecular area of the surfactants is
determined by the head group, as it increased going from
the ethylenediamine head group of 10 via the lysine head
group of 12 to the combined lysine/ethylenediamine head
group of 14. Electron microscopy showed that the surfactants
with the smaller head groups (10 and 12) form plate-like
structures, probably stacked bilayers, in line with the shape-
structure concept, whereas no structures are observed for the
largest surfactant 14. A CD spectroscopic titration of º-phage
Introduction
Gemini surfactants are a relatively new class of amphi-
philic molecules containing two head groups and two ali-
phatic chains, linked by a rigid[1,2] or flexible spacer.[3,4]
They have physicochemical properties that are different
from those of classical (single chain, single headgroup) sur-
factants,[5] including low critical aggregate concentration
values. It has recently been shown that cationic gemini sur-
factants can display high transfection activities,[628] i.e. they
can act as vehicles to introduce DNA across the mamma-
lian cell membrane into the biological cell. This property is
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DNA with surfactants 12 and 14 showed that there was some
interaction, although the secondary structure of the DNA was
hardly affected. The effects of the novel surfactants and com-
mercially available DOTAP [N-(2,3-dioleoyloxypropyl)-
N,N,N-trimethylammonium methyl sulfate] were identical
when compared on the basis of charge complimentarity, in-
dicating that the complexation of DNA with the surfactant is
a process of ion exchange. DNA binding was confirmed by
the ability of all surfactants (10, 12, and 14) to release ethid-
ium bromide from its complex with DNA in an agarose gel
electrophoresis experiment. Both lysine-containing surfact-
ants 12 and 14 showed activity in a luciferase gene-transfec-
tion assay but this was accompanied by a considerable tox-
icity.
of relevance for gene therapy, an approach to treat acquired
and inherited diseases by introducing a correct copy of the
defective gene into the cell.[9] Viruses are the most effective
transfection agents,[10] but their application is not without
risk for patients.[11] Various classical cationic surfactants
have been demonstrated to be effective in transfection,
like DOTMA [N-(2,3-dioleyloxypropyl)-N,N,N-trimethyl-
ammonium chloride, Figure 1],[12] now commercially avail-
able as LipofectinTM, DOTAP [N-(2,3-dioleoyloxypropyl)-
N,N,N-trimethylammonium methyl sulfate] and Lipofect-
AMINETM {based on DOSPA, N-(2,3-dioleoyloxypropyl)-
N,N-dimethyl-N -[2-(sperminecarboxamido)ethyl ]-
ammonium trifluoroacetate, Figure 1}.[13] As the mechan-
ism of gene transfer mediated by cationic surfactants is not
fully understood,[14,15] the strategy for the development is
as yet merely empirical.
We have recently explored the preparation and physico-
chemical properties of various surfactants based on bioc-
ompatible building blocks[16] including anionic gemini sur-
factants based on tartaric acid.[17219] The aforementioned
developments in the field of gene transfection prompted us
to explore the cationic analogues of such gemini surfact-
ants, as they might be expected to combine transfection effi-
ciency with biocompatibility and low toxicity. We present
here a convenient synthesis of a series of new gemini sur-
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Figure 1. Structures of efficient surfactants for transfection
factants (10, 12, and 14) based on tartaric acid, and the
results of studies of the aggregation of the compounds in
water and their interaction with DNA, along with an ex-
ploration of their transfection activity and toxicity.
Results and Discussion
Synthesis
The conversion of -(1)-tartaric acid into the benzyl-pro-
tected diol 1 was performed by using a literature proced-
ure.[20] Subsequent introduction of the alkyl chains and
catalytic removal of the benzyl groups afforded the key
compound 3 in an overall yield of 85% (Scheme 1). The
preparations of the protected head groups 6 and 8 started
from commercially available NÆ-Boc-Nå-Z--lysine (4,
Scheme 1). Amine 6 was obtained by treatment of 4 with
ethyl chloroformate and ammonia, followed[21] by removal
Scheme 1. (i) C15H31COCl, Et3N, DMAP, CHCl3, 0 °C 1 h, 85%; (ii) Pd/C/H2, MeOH, 2 h, 100%; (iii) a. EtOCOCl, Et3N, THF,
215 °C, 1 h; b. NH3(aq), 1 h, room temp., 73%; (iv) THF/TFA (4:1, v/v), 24 h, 61% (6), 85% (8); (v) HOBT, benzyl N-(aminoethyl)carba-
mate, DCC, CHCl3, 0 °C, 15 min, 24 h, room temp., 80%
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of the Boc group with trifluoroacetic acid. DCC coupling
of 4 with benzyl N-(aminoethyl)carbamate and subsequent
deprotection led to the amine 8. The DCC-assisted con-
densation of 3 with benzyl N-(aminoethyl)carbamate, fol-
lowed by treatment of the resulting compound 9 with HBr/
AcOH, gave surfactant 10 in acceptable yield (Scheme 2).
The preparation and isolation of the intermediates 11 and
13 by EDC coupling of 3 with 6 and 8, respectively, was
rather troublesome. Therefore, it was decided to use these
compounds without purification in the next step. Deprotec-
tion of 11 and 13 furnished the surfactants 12 and 14, re-
spectively. They were fully characterized by 1H, 13C NMR
and elemental analysis.
Monolayer and Aggregation Behaviour
Inspection of CPK models of the surfactants 10 and 12
revealed that the overall shape of these molecules is cylin-
drical, whereas for 14 the shape is cone-like. On the basis
of the shape-structure concept,[22] it was therefore expected
that the compounds 10 and 12 would form bilayer aggreg-
ates[17,19] upon dispersion in water, whereas compound 14
would form micellar structures. This was confirmed by ex-
amining sonicated dispersions of 10 and 12 in water at
pH 5 7.0 after 24 h at room temperature by using transmis-
sion electron microscopy (TEM). Plate-like structures were
observed for 10 (Figure 2, left) and 12 (Figure 2, right),
respectively. No distinct morphology was observed for gem-
ini surfactant 14 indicating that the aggregates of this com-
pound were too small to be observed with TEM, in line
with the anticipated formation of micellar structures. There
were also significant differences in the stabilities of the dis-
persions: 10 and 12 precipitated after 15 min and approxim-
ately 1 d, respectively, whilst solutions of compound 14 re-
mained homogeneous, even after two months.
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Scheme 2. (vi) 3, HOBT, benzyl N-(aminoethyl)carbamate, DCC, CHCl3, 0 °C, 15 min, 24 h, room temp., 77%; (vii) HBr/HOAc, room
temp., 15 min, 53% (10), 60% (12), 60% (14); (viii) 3, HOBT, Et3N, 6, EDC, CHCl3, 0 °C, 15 min, 24 h room temp., 27%; (ix) 3, HOBT,
Et3N, 8, EDC, CHCl3, 0 °C, 15 min, 24 h, room temp., 60%
Figure 2. Electron micrographs of dispersions of (left) 10 and (right) 12 at pH 5 7.0; bar represents 150 nm
The film-forming capabilities of the gemini surfactants at
the air/water interface were also investigated, viz. by mono-
layer studies in a Langmuir trough (Figure 3). Surfactant
10 formed a condensed film and the molecular area, deter-
mined by extrapolating the slope of the curve to zero pres-
sure, is in good agreement with the molecular area derived
from CPK models, namely ca. 50 A˚2/molecule. The ð/A iso-
therm of 12 showed a pressure fall when the surface area
was decreased to 40 A˚2, whereas a normal increase in sur-
face pressure was observed upon further compression. In
the latter phase, Brewster angle microcopy (not shown) re-
vealed a continuous densification and an increase in intens-
Eur. J. Org. Chem. 2002, 139721406 1399
Figure 3. Monolayer isotherms of gemini surfactants 10, 12, and
14 recorded on a subphase of pH 5 7.0 (10 m PIPES) at 20 °C
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ity of the image. Since no abrupt pressure falls, which would
have indicated a collapse, were observed, and the calculated
molecular area was approximately 38240 A˚2/molecule, cor-
responding to the area of two alkyl chains, these observa-
tions suggest that 12 forms bilayers. A very large lift-off
area of approximately 275 A˚2 was determined for 14 and
no condensed phase was observed upon compression, indic-
ating that the molecular shape was determined by the size
of its head group. In previous studies from our laborat-
ory[18,19] on anionic analogues of 10, 12, and 14 it was dem-
onstrated that Newman projections along the C22C3 bond
of the tartaric acid can provide insight into the most favour-
able spatial orientation of the substituents on the carboxylic
acid function. Conformations in which the long tails are
antiperiplanar should be neglected, since these are unfa-
vourable in terms of hydrocarbon chain organization. Ac-
cording to this analysis the head groups of compound 10
can be expected to have either a gauche or anti orientation
(Figure 4, i and ii). The latter, although sterically more de-
manding, will be more favourable, because of its lower de-
gree of charge repulsion. The aliphatic moiety between the
primary amide and the ammonium group of 12 possesses
more flexibility than the corresponding moiety in 10, and
as a consequence, the head groups of 12 are less restricted
in their orientations allowing both a gauche and an anti
conformation (Figure 4, iii and iv). For 14 probably only
the anti conformation is allowed due to the bulkiness and
the unfavourable charge repulsion of the head groups (Fig-
ure 4, v), leading to a film in which the surfactants require
a large surface area.
Circular Dichroism Measurements on the Complexes
To determine whether structural changes occur upon
binding of cation surfactants to DNA, circular dichroism
Figure 4. Newman projections of 10 (i, ii), 12 (iii, iv), and 14 (v)
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(CD) experiments were performed. Nucleic acids are poly-
morphic in secondary structures,[23225] i.e. the number of
base pairs per turn, the inclination of the bases with respect
to the helical axis as well as the handedness of the helix
depend on the solvent conditions. CD spectra of DNA
strongly depend on the interactions of the complementary
bases and are therefore very sensitive to the secondary
structure of the nucleic acid.[26] CD experiments were con-
ducted on solutions of double-stranded º-phage DNA con-
taining various concentrations of gemini surfactants 12 and
14. Due to the aforementioned instability of aqueous dis-
persions of 10 it was not possible to obtain reproducible
CD results for this compound. For comparison commer-
cially available surfactant DOTAP,[27230] which is known
to bind to the DNA, was also studied. The º-phage DNA
displayed in its CD spectrum the typical B-form signa-
ture[31,32] of a positive band centered near 278 nm, a nega-
tive band near 245 nm and a crossover point at ca. 258 nm,
the latter corresponding to the wavelength maximum in the
UV spectrum (Figure 5a). The intensity of the peaks at 278
and at 245 nm decreased when the concentrations of com-
pounds 12, 14, and DOTAP were increased going from an
ammonium/phosphate charge ratio of 0 to approximately 4
(Figure 5b2d). The changes in the intensity of the CD peak
centered at 278 nm have been associated with alterations
of hydration shell of the DNA helix in the vicinity of the
phosphate or the ribose ring when ionic concentrations are
modified.[33] It is reasonable to assume that cationic surfact-
ants will exchange with sodium ions present on the DNA
surface, which in turn will lead to changes in the hydration
shell near the phosphate groups. The decrease in the CD
intensity is small, suggesting that hydration changes are
small. Thus, there is no major change in conformation of
the secondary structure of the DNA upon binding of the
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Figure 5. (A) UV spectrum of º-phage DNA; (B) circular dichro-
ism spectra of º-phase DNA with increasing amounts of 12 at
pH 5 7.0 (10 m PIPES); circular dichroism spectra of º-phage
DNA in aqueous 10 m PIPES containing various amounts of (C)
14 and (D) DOTAP at pH 5 7.0, 25 °C
surfactants to the duplex. When comparing our results to
those of a study of the interaction of classical lipids with
DNA,[34] where it was found that only bilayer-forming
lipids brought about conformational change, the lack of
such an effect is not unexpected for the non-bilayer com-
pound 14, whereas it would have been expected for the bi-
layer-forming 12. We note, however, that in our study DO-
TAP does not induce a conformational change either, con-
trary to earlier reports in the literature.[35] The difference
Eur. J. Org. Chem. 2002, 139721406 1401
Figure 6. Peak height of the CD band at 278 nm plotted against
the [surfactant]/[phosphate] ratio (top) and the [ammonium]/[phos-
phate] (charge) ratio (bottom)
may be due to the fact that our titrations were carried out
in water in the absence of salts; such circumstances are
known to favour the B configuration of DNA.[35]
The intensity of the positive band at 278 nm was propor-
tional to the amount of added surfactant. CD intensities
were determined using curve fitting procedures and plotted
against both the [surfactant]/[phosphate] ratio (Figure 6,
top) and the [ammonium groups]/[phosphate] ratio (Fig-
ure 6, bottom). These curves show (after compensation for
the number of charges per molecule) that the CD intensity
decreases when the number of charges increases. No differ-
ences are observed between the surfactants tested, i.e. struc-
tural modifications going from DOTAP to surfactants 12
and 14 neither have an influence on the CD spectrum, nor
on the CD intensities as a function of the concentration.
Surfactant/DNA complexes with different ammonium/
phosphate ratios were investigated using transmission elec-
tron microscopy, but only ill-defined aggregates were ob-
served.
Gel Electrophoresis and Gene Transfection of the Cationic
Surfactant/DNA Complexes
To examine the complex formation of the gemini surfact-
ants with the pCMV-luciferase plasmid DNA, which was
used for the transfection experiments, varying amounts of
the compounds 10, 12, and 14 were added to the DNA.
The DNA was preincubated with a solution of the probe
ethidium bromide (3,8-diamino-5-ethyl-6-phenylphen-
anthridium bromide), which gives a fluorescent complex
with DNA, and the resulting mixtures were subjected to
electrophoresis in agarose gel. After the gel electrophoresis
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of the resulting mixture, the loss of fluorescence was taken
as a measure of the capacity of the gemini surfactant to
liberate the probe from its complex with DNA.[628] It was
found that all gemini surfactants studied interact with the
luciferase plasmid DNA; this is in line with the CD results
for the complexation of compounds 12 and 14 by º-phage
DNA. Transfection experiments[628] were carried out using
CHO-K1 cells and the pCMV-luciferase plasmid DNA.
Gene transfection activities for compound 10, 12, and 14
were characterized as I (not active), III (active), and III/IV
(active), respectively. Compounds 12 and 14 were found to
display more than average toxicity, resulting in death of up
to 30% of the cells used in the transfection experiments.
Such a high toxicity is not typical for cationic gemini
surfactants[628] and was not anticipated for 12 and 14 in
view of the expected biocompatibility of the tartaric acid
skeleton, the carboxylic acid tails, and the amino acid head
groups. The toxicity could be due to the compounds them-
selves or to products resulting from biodegradation, e.g. the
single alkyl chain product resulting from enzymic splitting
of one of the ester bonds, which is likely to be the first
target. By analogy to the single-chain phospholipids, the so-
called lysophospholipids, such compounds could have an
anomalously high toxicity due to their strong detergent
properties.[36] This possibility was not further investigated.
Concluding Remarks
Starting from -tartaric acid three novel surfactants (10,
12, and 14) with palmitoyl tails and ammonium and/or am-
ino acid head groups were conveniently synthesized in ac-
ceptable yields. Going from 10 to 12 and then to 14, the
introduction of larger head groups is clearly detectable in
the molecular area as derived from monolayer studies on a
Langmuir film balance, and results in a change in the ag-
gregate morphology of the surfactants, in line with the
shape-structure[22] concept. Compounds 10 and 12 form
stacked bilayers and precipitate from their aqueous disper-
sions in 15 min and approximately 1 d, respectively, whereas
aqueous dispersions of compound 14 are more stable but
have no distinct morphology. CD spectroscopy showed that
compounds 12 and 14 interacted with º-phage DNA, al-
though the changes induced in the DNA structure by the
cationic surfactants were relatively small. The complexation
of the DNA is determined by the charge of the surfactant
molecule rather than by other details of the molecular
structure, which is in line with a mechanism of complex
formation by ion exchange, resulting in charge compli-
mentarity between the DNA and the cationic surfactant
molecules. The gemini surfactants 12 and 14 showed mod-
erate activity as carriers for mediating gene transfer to cells,
which is encouraging, whereas 10 was not active.
Thus far, little is known about the relation between the
molecular structure of a vector and its related gene transfer
activity.[13] There must be a delicate balance, however, be-
tween the factors required for complexation of the cytofec-
tin with DNA to provide a suitable carrier system, such as
Eur. J. Org. Chem. 2002, 1397214061402
the charge complimentarity mentioned above, and those
that are responsible for the disassembly of the complex
when it arrives at its target site. In this respect it can be
predicted that surfactants which display a high degree of
self-organization will show less transfection activity.[37] In
the present study, compounds 10 and 12 were found to as-
semble into stacked bilayers, whereas 14 gave stable solu-
tions with no defined aggregate morphology. It can there-
fore be concluded that these compounds do show an inverse
correlation between degree of self-organization and trans-
fection efficiency. Before generalizing these conclusions,
however, one has to consider that the transfection results
were complicated by unexpected toxicity effects. Further ef-
forts in the development of biocompatible cationic gemini
surfactants with lysine as the building block are in progress.
Experimental Section
General Remarks: Thin layer chromatography analyses were per-
formed on Merck precoated silica gel 60 F254 plates (0.25 mm)
using the solvent mixtures indicated and spots were visualized with
UV and/or using ammonium molybdate (25 g/L) and ceric ammo-
nium sulfate (10 g/L) in aqueous 10% H2SO4. Flash column chro-
matography was performed on Merck kieselgel 60H
(0.00520.040 mm) using a pressure of ca. 0.5 bar and the eluents
indicated. Melting points were measured with a Reichert thermo-
pan microscope equipped with crossed polarizers. Optical rotations
were determined at 20 °C using a Perkin2Elmer automatic polari-
meter, model 241. Routine FT-IR spectra were recorded using a
Biorad WIN-IR FTS-25 single-beam spectrometer. 1H NMR and
13C NMR spectra were recorded with a Bruker AC 300 (300/
75.1 MHz) spectrometer. 1H and 13C chemical shifts are given in
ppm (ä) relative to Me4Si as internal standard. Mass spectra were
recorded with a double-focusing VG 7070E spectrometer. Ele-
mental analyses were determined with a Carlo Erba Instruments
EA 1108 element analyser.
Chemicals: Diethyl ether was pre-dried with potassium hydroxide,
then distilled from sodium/benzophenone. Dichloromethane and
chloroform were distilled from CaH2. Ethyl acetate and hexane
were distilled under reduced pressure using a rotary evaporator.
Synthesis
Dibenzyl (2R,3R)-2,3-Dihydroxybutanedioate (1): This compound
was prepared from -(1)-tartaric acid by a literature procedure.[20]
Dibenzyl (2R,3R)-2,3-Bis(hexadecanoyloxy)butanedioate (2): A so-
lution of 1 (1.01 g, 3.1 mmol) in CHCl3 (20 mL) with triethylamine
(1 mL, 7.2 mmol) and a catalytic amount of DMAP was gradually
added to a cooled (0 °C) solution of hexadecanoyl chloride (1.71 g,
6.2 mmol) in CHCl3 (10 mL). The reaction mixture was allowed to
warm to room temperature and then stirred for a further 1 h. The
reaction mixture was diluted with CHCl3 and washed with 1.5 
HCl, 10% (w/v) NaHCO3 solution, brine, dried (MgSO4), and con-
centrated in vacuo. The residue was recrystallized from acetonitrile
to furnish 2.1 g (85%) of 3 as a white solid. M.p. 64.3265.0 °C.
[Æ]D20 5 119.9 (c 5 3.3, CHCl3). IR(KBr): í˜ 5 2917 cm21, 2850
(C2H alkyl), 1770, 1743 (2 3 C5O), 1200, 1160 (2 3
alkyl2O2C). 1H NMR (300 MHz, CDCl3): ä 5 7.3527.26 (m, 10
H, 2 3 OCH2C6H5), 5.74 [s, 2 H, 2 3 C(O)OCH], 5.15 (AB, J 5
12.1 Hz, 4 H, 2 3 OCH2C6H5), 2.3322.08 (m, 4 H, 2 3
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C14H29CH2), 1.5421.49 (m, 4 H, 2 3 C13H27CH2CH2), 1.25 (m,
48 H, 2 3 CH3C12H24C2H4), 0.88 (t, J 5 6.4 Hz, 6 H, 2 3 CH3).
13C NMR (75 MHz, CDCl3): ä5 172.38 [2 3 C(O)OCH], 165.72
[2 3 CHC(O)OCH2C6H5], 134.77 (2 3 quat. C6H5), 128.60, 128.46
(o-, m-, p-C6H5), 70.53 [2 3 OCHC(O)], 67.66 (2 3 OCH2C6H5),
33.42 [2 3 CH2C(O)O], 31.91, 29.70, 29.47, 29.37, 29.24, 28.95,
24.57, 22.68 (2 3 CH3C13H26), 14.01 (2 3 CH3). C50H78O8 (806.8):
calcd. C 74.40, H 9.74; found C 73.64, H 9.76.
(2R,3R)-2,3-Bis(hexadecanoyloxy)butanedioic Acid (3): A solution
of compound 2 (1.20 g, 1.9 mmol) in ethyl acetate (200 mL) was
subjected to catalytic hydrogenolysis (Pd/C) for 2 h. The catalyst
was removed by filtration using a small RP-18 column and washed
with hot ethyl acetate, and the filtrate was concentrated in vacuo
to give 1.19 g (100%) of 3. M.p. 131.52132.2 °C. [Æ]D20 5 28.8 (c 5
5.2, CHCl3). IR(KBr): í˜ 5 350022700 cm21 [C(O)2OH], 2916,
2849 (CH alkyl), 1748 [(C5O)O], 1728 [C(5O)OH], 1153
[C(O)2O2CH]. 1H NMR (300 MHz, CDCl3): ä 5 5.76 [s, 2 H, 2
3 C(O)OCHC], 2.44 [m, 4 H, 2 3 CH2C(O)O], 1.64 [m, 4 H, 2 3
CH2CH2C(O)O], 1.25 (m, 48 H, 2 3 CH3C12H24C2H4), 0.88 (t,
J 5 6.3 Hz, 2 3 CH3C14H28). 13C NMR (75 MHz, CDCl3): ä 5
172.45 [2 3 C(O)OCH], 170.28 (2 3 COOH), 70.02 [2 3
OCHC(O)], 33.58 [2 3 CH2C(O)O], 31.92, 29.70, 29.47, 29.36,
29.22, 28.97, 24.65, 22.68, (2 3 CH3C13H26), 14.01 (2 3 CH3).
C36H66O8 (626.7): calcd. C 68.97, H 10.61; found C 68.77, H 10.54.
Boc-L-Lys(Z)-NH2 (5): A stirred solution of Boc--Lys(Z)-OH (4,
4.0 g, 10.5 mmol) in dry THF (70 mL) was treated with triethylam-
ine (1.5 mL). The reaction mixture was cooled to 215 °C and then
treated with ethyl chloroformate (1.4 mL) and the solution was
stirred for 1 h at room temperature. The mixture was treated with
25% (v/v) aqueous ammonia (6 mL), stirred overnight at room tem-
perature, and then concentrated in vacuo. The residue was dis-
solved in ethyl acetate and subsequently washed with 10% (w/v)
Na2CO3 solution, and brine, dried (MgSO4), and concentrated in
vacuo to give 2.91 g (73%) of 5. 1H NMR (300 MHz,CDCl3): ä 5
7.3527.30 (m, 5 H, C6H5), 6.19 (br. s., 1 H, NH), 5.34 (br. s., 1 H,
NH), 5.23 (br. s., 1 H, NH), 5.09 (s, 2 H, OCH2C6H5), 4.92 (br. s.,
1 H, NH), 4.1024.08 (m, 1 H, CH), 3.19 [q, J 5 6.1 Hz, 2 H,
(CH2)3CH2], 1.8821.37 [m, 6 H, (CH2)3CH2], 1.43 [s, 9 H,
(CH3)3C]. 13C NMR (75 MHz, CDCl3): ä 5 175.45 (CONH2),
156.08 [NHCOOBn, (CH3)3COCO], 137.04 (quat., C6H5), 128.53,
128.12 (o-, m-, p-C6H5), 79.47 [(CH3)3C], 66.69 (OCH2C6H5), 53.84
(CH), 40.28 [(CH2)3CH2], 31.62, 29.46, 22.34 [(CH2)3CH2], 28.32
[(CH3)3C].
H-L-Lys(Z)-NH2 (6): Trifluoroacetic acid (5 mL) was added to a
solution of 5 (1.46 g, 13.8 mmol) in dry THF (20 mL) and the
reaction mixture was stirred overnight at room temperature. The
mixture was concentrated in vacuo and the residue was dissolved
in CH2Cl2 and subsequently washed with 10% (w/v) NaHCO3 solu-
tion and brine, dried (Na2SO4), and concentrated in vacuo to give
0.65 g (61%) of 6. 1H NMR (300 MHz, CDCl3): ä 5 7.4527.36
(m, 5H, C6H5), 7.06 (br. s, 1H, NH), 5.45 (br. s, 2H, NH2), 5.09 (s,
2 H, OCH2), 4.83 (br. s, 1 H, NH), 3.36 (dd, J 5 4.5, 7.6 Hz, 1
H, CH), 3.2422.99 [m, 2 H, CH2NHC(O)O], 2.021.28 [m, 6 H,
CH(CH2)3]. 13C NMR (75 MHz, CDCl3): ä 5 177.90
[CH2C(O)NH2], 156.48 [NHC(O)O], 136.59 (quat. C6H5), 128.51
(o, m-C6H5), 128.09 (p-C6H5), 69.75 (CH2O), 58.80 (CHNH2),
40.63 (CH2NH), 34.48 (CH2CHNH2), 29.75 (CH2CH2NH), 22.75
(CH2CH2CH2NH).
Boc-L-Lys(Z)-(CH2)2NH-Z (7): A cooled (0 °C) solution of Boc--
Lys(Z)-OH (2.5 g, 6.6 mmol) in CHCl3 (50 mL) was treated with a
solution of benzyl N-(2-aminoethyl)carbamate (2.3 g, 12.0 mmol)
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and 1-hydroxybenzotriazole (1.78 g, 13.4 mmol), dissolved in
CHCl3 (20 mL). DCC (dicyclohexylcarbodiimide, 2.78 g,
13.4 mmol) was then added in small portions. The reaction mixture
was stirred for 15 min at 0 °C and then overnight at room temper-
ature. Subsequently it was filtered and the filtrate was concentrated
in vacuo. Flash chromatography (SiO2, CHCl3/MeOH, gradient
99:1 to 95:5) gave 2.94 g (80%) of 7. 1H NMR (300 MHz, CDCl3):
ä 5 7.3427.26 (m, 10 H, 2 3 C6H5), 6.53 (br. s, 1 H, NH), 5.38
(br. s, 1 H, NH), 5.08 (s, 4 H, 2 3 OCH2C6H5), 4.90 (br. s, 1 H,
NH), 3.9823.94 (m, 1 H, CH), 3.3923.31 [m, 4 H, NH(CH2)2NH],
3.17 [q, J 5 6.3 Hz, 2 H, CH(CH2)3CH2], 1.6721.25 [m, 6 H,
CH(CH2)3CH2], 1.42 [s, 9 H, (CH3)3C]. 13C NMR (75 MHz,
CDCl3): ä 5 172.99 (CHCONH), 156.77, 156.49, 155.64 [2 3
NHCOOC6H5, NHCOOC(CH3)3], 136.41, 136.27 (2 3 quat.
C6H5), 128.20, 127.76 (2 3 o-, m-, p-C6H5), 79.58 [(CH3)3C], 66.36,
66.24 (2 3 OCH2C6H5), 54.32 (CH), 40.46, 40.18, 39.42
[NH(CH2)2NH, CH(CH2)3CH2], 31.84, 29.08, 22.31
[CH(CH2)3CH2].
H-L-Lys(Z)-(CH2)2NH-Z (8): Compound 8 (2.05 g, 85%) was ob-
tained from 7 (2.94 g, 5.3 mmol) in the manner as described for the
preparation of 6 from 5. 1H NMR (300 MHz, CDCl3): ä 5 7.55
(br. s, 1 H, NH), 7.34 (m, 10 H, 2 3 C6H5), 5.32 (br. s, 1 H, NH),
5.08 (s, 4 H, 2 3 OCH2C6H5), 4.86 (br. s, 1 H, NH), 3.3823.27
[m, 6 H, NH(CH2)2NH, NHCHCONH], 3.2123.15 [m, 2 H,
(CH2)3CH2], 1.7921.29 [m, 6 H (CH2)3CH2]. 13C NMR (75 MHz,
CDCl3): ä 5 172.55 (CHCONH), 158.30, 156.83 (2 3
NHCOOC6H5), 136.57, 136.49 (2 3 quat. C6H5), 128.517, 128.15,
128.08, 127.99, 127.77 (2 3 o-, m-, p-C6H5), 66.70 (2 3
OCH2C6H5), 53.03 (CHCONH), 41.35, 40.60, 39.29
[NH(CH2)2NH, (CH2)3CH2], 34.43, 29.74, 22.64 [(CH2)3CH2].
(1)-(1R,2R)-3-({2-[(Benzyloxycarbonyl)amino]ethyl}amino)-1-[({2-
[(benzyloxycarbonyl)amino]ethyl}amino)carbonyl]-3-oxo-2-(hexa-
decanoyloxy)propyl Hexadecanoate (9): A cooled (0 °C) solution of
3 (870 mg, 1.39 mmol) in CHCl3 was treated with a solution of
benzyl N-(2-aminoethyl)carbamate (760 mg, 3.96 mmol) and 1-hy-
droxybenzotriazole (376 mg, 2.78 mmol) in CHCl3 (10 mL). DCC
(580 mg, 2.8 mmol) was then added in small portions. The reaction
mixture was stirred for 15 min at 0 °C and then overnight at room
temperature. Subsequently, it was filtered and the residue was
washed with CHCl3 (2 3 20 mL). The filtrate was concentrated in
vacuo and flash column chromatography (CHCl3/MeOH, 95:5
(v/v)] gave 1.05 g (77%) of 9 as a white solid. M.p. 134 °C (decomp.).
[Æ]D20 5 18.5 (c 5 1.0, CHCl3). IR(KBr): í˜ 5 3319 (N2H) cm21,
3099 (C2H aromatic), 2917, 2849 (C2H alkyl), 1741 [C5O(O)],
1692 (Am I, urethane), 1670 (Am I), 1546 (Am II), 1536 (Am II,
urethane), 1170 (alkyl2O2C). 1H NMR (300 MHz, CDCl3): ä 5
7.3527.25 (m, 10 H, OCH2C6H5), 6.71 (m, 2 H, 2 3 NH), 5.47 [s,
2 H, OCHC(O)], 5.44 (m, 2 H, 2 3 NH), 3.3523.23 [m, 8 H, 2 3
NH(CH2)2NH], 2.4122.37 [m, 4 H, CH2C(O)O], 1.6221.57 [m, 4
H, CH2CH2C(O)O], 1.25 (m, 48 H, 2 3 CH3C12H24C2H4), 0.88 (t,
6 H, 2 3 CH3). 13C NMR (75 MHz, CDCl3): ä 5 172.26 [2 3
C(O)OCH], 166.92 (2 3 CONH), 157.21 [2 3 NHC(O)OCH2],
136.33 (2 3 quat. OC6H5), 128.48 (4 3 m-C6H5), 128.10 (2 3 p-
C6H5), 128.03 (4 3 o-C6H5), 72.15 [2 3 OCHC(O)O], 66.81 (2 3
OCH2C6H5), 40.48 [2 3 CH2CH2NC(O)O], 39.98 [2 3
CH2CH2NC(O)O], 33.76, 31.92, 30.28, 29.67, 29.49, 29.31, 29.07,
25.57, 24.91, 24.64, 22.66, [2 3 CH3(CH2)14], 14.09 (2 3 CH3).
C56H90N4O10 (978.9): C 68.68, H 9.26, N 5.72; found C 68.70, H
9.46, N 5.78.
(1)-[2-({(2R,3R)-4-[(Ammonioethyl)amino]-2,3-bis(hexadecanoyl-
oxy)-4-oxobutanoyl}amino)ethyl]ammonium Dibromide (10): HBr in
acetic acid [15 mL, 33%, (v/v)] was added to 9 (450 mg, 0.46 mmol)
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and the reaction mixture stirred for 15 min at room temperature.
Diethyl ether (10 mL) was added and the white precipitate was
filtered and washed with diethyl ether (3 3 20 mL). Recrystalliza-
tion from MeOH gave 219 mg (53%) of 10 as a white solid. M.p.
104 °C (decomp). [Æ]D20 5 4.7 (c 5 1.0, MeOH). IR(KBr): í˜ 5 3370
(N2H) cm21, 3050 (N2H, NH31), 2918, 2850 (CH alkyl), 1745
[C5O(O)], 1641 (Am I), 1547 (Am II), 1162 [alkyl2O2C(O)]. 1H
NMR (300 MHz, CD3OD): ä 5 5.49 [s, 2 H, 2 3 OCHC(O)], 4.51
[m, 2 H, 2 3 C(O)NH], 3.4723.38 (m, 4 H, 2 3 CH2CH2NH31),
2.99 (t, J 5 6.0 Hz, 4 H, 2 3 CH2CH2NH31), 2.40 [dt, J 5 7.5 Hz,
2 3 CH2C(O)O], 1.5821.54 [m, 4 H, 2 3 CH2CH2C(O)O], 1.25
[m, 48 H, 2 3 CH3(CH2)12C2H4], 0.83 (t, J 5 6.3 Hz, 6 H, 2 3
CH3). 13C NMR (75 MHz, CD3OD): ä 5 174.23 [2 3 C(O)OCH],
170.01 [2 3 CHC(O)NH], 73.63 [2 3 OCHC(O)NH], 40.68 (2 3
CH2CH2NH31), 38.13 (2 3 CH2CH2NH31), 34.62 [CH2C(O)O],
33.09, 30.82, 30.68, 30.49, 30.20 [2 3 CH3(CH2)14], 14.45 (2 3
CH3). C40H80Br2N4O6·1.5H2O (899.7): C 53.39, H 9.18, N 6.22;
found C 53.39, H 9.00, N 6.23.
(1R,2R)-3-({[(1R)-1-(Aminocarbonyl)-5-[(benzyloxycarbonyl)-
amino]pentyl}amino)-1-[({(1R)-1-(aminocarbonyl)-5-[(benzyloxy-
carbonyl)amino]pentyl}amino)carbonyl]-2-(hexadecanoyl-
oxy)-3-oxopropyl Hexadecanoate (11): A cooled (0 °C) solution of
3 (713 mg, 1.13 mmol) in CHCl3 (10 mL) was treated with a mix-
ture of 1-hydroxybenzotriazole (368 mg, 2.85 mmol), triethylamine
(0.54 mL, 2.9 mmol), and amine 6 (1.29 g, 2.85 mmol) in CHCl3
(10 mL), followed by a solution of N-(3-dimethylamino)propyl-N9-
ethylcarbodiimide (403 mg, 2.85 mmol) in CHCl3 (10 mL). The re-
action mixture was stirred for 10 min at 0 °C and left overnight at
room temperature, diluted with CHCl3, and subsequently washed
with 1.5  HCl, 10% (w/v) NaHCO3 solution, and brine, dried
(MgSO4) and concentrated in vacuo. The residue was purified by
flash column chromatography (SiO2, gradient CHCl3/MeOH, 98:2
to 95:5) to afford 350 mg (27%) of 11 as a colourless oil. IR(KBr):
í˜ 5 3274 cm21 (N2H), 2919, 2850 (C2H, alkyl), 1745 [C5O(O)],
1690 (Am I, urethane), 1660 (Am I, primary), 1650 (Am I, second-
ary), 1548 (Am II). 1H NMR (300 MHz, CDCl3): ä 5 7.32 (m, 10
H, 2 3 C6H5), 5.48 (s, 2 H, 2 3 OCOCH), 5.08 (s, 4 H, 2 3
CH2O), 4.43 (m, 2 H, 2 3 CHCONH2), 3.2123.15 (m, 4 H, 2
3 CH2NHCOOC6H5), 2.37 (t, J 5 7.5 Hz, 4 H, 2 3 CH2COO),
1.6121.25 [m, 64 H, 2 3 (CH2)3CH2, 2 3 CH3(CH2)13CH2CO],
0.87 (t, J 5 6.9 Hz, 2 3 CH3). 13C NMR (75 MHz, CDCl3): ä 5
174.58 (2 3 CONH2), 172.56 [2 3 CHC(O)NH], 166.18 [2 3
C(O)O], 156.68 [2 3 NHC(O)OC6H5], 137.11 (2 3 quat. C6H5),
128.51, 128.08, 127.99 (o-, m-, p-C6H5), 72.37 (2 3 CHOOC), 66.58
(2 3 OCH2C6H5), 52.73 (2 3 CHCONH2), 40.31 (2 3
CH2NHCOOCH2C6H5), 33.75 (2 3 CH2COO), 31.91, 29.70,
29.53, 29.35, 29.19, 29.09, 25.63, 24.68, 22.68 [2 3 (CH2)3CH2, 2
3 CH3(CH2)13], 14.11 (2 3 CH3).
(2)-[(5R)-6-Amino-5-{[(2R,3R)-4-{[(1R)-1-(aminocarbonyl)-5-
ammoniopentyl]amino}-2,3-bis(hexadecanoyloxy)-4-oxobutanoyl]-
amino}-6-oxohexyl)ammonium Dibromide (12): Compound 12
(192 mg, 60%) was obtained from 11 by using the same procedure
as for the preparation of 10 from 9, as a white solid. M.p. 189°
(decomp.). [Æ]D20 5 22.63 (c 5 0.97, MeOH). IR(KBr): í˜ 5 3275
(N2H) cm21, 2919, 2849 (C2H alkyl). 1H NMR (300 MHz,
CD3OD): ä 5 5.43 (s, 1 H, 2 3 OCHCO), 4.27 (dd, J 5 4.9, J 5
8.9 Hz, 2 H, 2 3 CHCONH2), 2.83 (t, J 5 7.6 Hz, 4 H, 2 3
CH2NH31), 2.39 (t, J 5 7.5 Hz, 4 H, 2 3 CH2COO), 1.8621.77
[m, 2 H, 2 3 CHH(CH2)3NH31], 1.6821.52 (m, 10 H, 2 3
CHHCH2CH2CH2NH31, 2 3 CH2CH2COO), 1.3921.20 [m, 52
H, 2 3 CH2CH2CH2CH2NH31, 2 3 CH3(CH2)12], 0.81 (t, J 5
6.9 Hz, 6 H, 2 3 CH3). 13C NMR (75 MHz, MeOD): ä 5 175.81
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(2 3 COO), 174.22 (2 3 CONH2), 168.57 (2 3 CONH), 73.84 (2
3 OCHCO), 53.79 (2 3 CHCONH2), 40.53 (2 3 CH2NH31),
34.57, 33.07, 32.35, 30.81, 30.67, 30.46, 30.19, 27.98, 25.84, 23.72,
23.54 [2 3 CH3(CH2)14, 2 3 (CH2)3CH2], 14.43 (2 3 CH3).
C48H94Br2N6O8·0.5H2O (1052.1): calcd. C 55.27, H 9.08, N 8.06;
found C 55.04, H 8.73, N 8.07.
(1R,2R)-3-({(1S)-5-[(Benzyloxycarbonyl)amino]-1-[({2-[(benzyloxy-
carbonyl)amino]ethyl}amino)carbonyl]pentyl}amino)-1-[({(1S)-
5-[(benzyloxycarbonyl)amino]-1-[({2-[(benzyloxycarbonyl)amino]-
ethyl}amino)carbonyl]pentyl}amino)carbonyl]-2-(hexadecanoyloxy)-
3-oxopropyl Hexadecanoate (13): Compound 13 (342 mg, 60%) was
obtained from 3 and 8 by using the same procedure as described
for the preparation of 11 from 3 and 6. IR (KBr): í˜ 5 3324, 3278
(N2H) cm21, 3068, 3034 (C2H, aromatic), 2921, 2850 (C2H, al-
kyl), 1744 [C5O(O)], 1689 (Am I, urethane), 1648 (Am I), 1544
(Am II). 1H NMR (300 MHz, CDCl3/CD3OD): ä 5 7.68 (br. s, 2
H, NH), 7.4527.28 (m, 20 H, 4 3 C6H5), 6.50 (br. s, 2 H, NH),
6.27 (br. s, 2 H, NH), 5.44 (s, 2 H, OCHCO), 5.07 (s, 8 H, 4 3
OCH2C6H5), 4.26 (br. s, 2 H, NH), 3.2923.15 [m, 10 H, 2 3
NHCHCONH, 2 3 (CH2)2], 3.1323.10 [m, 4 H, 2 3 (CH2)3CH2],
2.4322.41 (m, 4 H, 2 3 CH2COO), 1.8521.00 [m, 64 H, 2 3
(CH2)3CH2, CH3(CH2)13], 0.87 (t, J 5 6.7 Hz, 2 3 CH3). 13C NMR
(75 MHz, MeOD): ä 5 172.62 (COO), 171.77 (2 3 CHCONH),
166.55 (2 3 OCHCONH), 156.92 (4 3 NHCOOC6H5), 136.23 (4
3 quat. C6H5), 127.92, 127.47, 127.26 (4 3 o-, m-, p-C6H5), 72.15
(2 3 OCOCHCONH), 66.11, 65.98 (4 3 CH2C6H5), 52.78 (2 3
NHCHCONH), 39.19, 39.07, 33.18, 33.10, 31.41, 29.18 29.02,
28.84, 28.79, 28.58, 22.14 [2 3 (CH2)2, 2 3 (CH2)3CH2, 2 3
CH3(CH2)14], 13.35 (2 3 CH3).
(2)-(2-{[(2S)-6-Ammonio-2-{[(2R,3R)-4-{[(1S)-5-ammonio-1-{[(2-
ammonioethyl)amino]carbonyl}pentyl]amino}-2,3-bis(hexadecanoyl-
oxy)-4-oxobutanoyl]amino}hexanoyl]amino}ethyl)ammonium Tetra-
bromide (14): Compound 14 (205 mg, 60%) was obtained from 13,
by using the same procedure as for the preparation of 10 from 9,
as a white solid. M.p. 205° (decomp.). [Æ]D20 5 20.95 (c 5 1.0,
MeOH). IR (KBr): í˜ 5 3428, 3275 (N2H, amides) cm21, 2919,
2849 (C2H, alkyl), 1734 [C5O(O)], 1659 (Am I), 1556 (Am II).
1H NMR (300 MHz, CD3OD): ä 5 5.57 (s, 2 H, 2 3 OCHCONH),
4.25 (dd, J 5 4.9 Hz, 2 H, NHCH), 3.47 (m, 4 H, 2 3
CH2CH2NH31), 3.05 (t, J 5 5.8 Hz, 4 H, 2 3 CH2CH2NH31),
3.11 [t, J 5 7.6 Hz, 4 H, 2 3 (CH2)3CH2], 2.46 (dt, J 5 7.5 Hz, 4
H, 2 3 CH2COO), 2.0021.58 (m, 12 H, 2 3 CH2CH2CH2CH2, 2
3 CH2CH2COO), 1.5021.25 [m, 52 H, 2 3 CH2CH2CH2CH2, 2
3 CH3(CH2)12], 1.06 (t, J 5 6.8 Hz, 6 H, 2 3 CH3). 13C NMR
(75 MHz, CD3OD): ä 5 174.48 (2 3 COO), 169.13 (4 3 CONH),
73.84 (OCHCO), 54.96 (2 3 CHCONH), 40.71, 40.51 (4 3
CH2NH31), 38.26, 34.76, 33.07, 31.63, 30.83, 30.50, 30.26, 28.00,
25.91, 23.87, 23.73 [2 3 CH2CH2NH31, 2 3 (CH2)3CH2,
CH3(CH2)14], 14.43 (2 3 CH3). C52H106Br4N8O8·2.5H2O (1336.1):
calcd. C 46.75, H 8.18, N 8.39; found C 46.83, H 7.90, N 8.32.
Electron Microscopy: A 2% (w/v) methanolic solution (50 ìL) of
10, 12, or 14 (typical 1 mg) was injected into 1.0 mL of water at 60
°C, adjusted to pH 5 7.0 with 10 m PIPES, and sonicated at this
temperature for 30 min. The sonicator was an Elma Transsonic
Digital T480/H-2 (power approx. 600 W). The dispersion was co-
oled to room temperature and left to stand for 24 h before EM
samples were prepared. Pt-shadowed samples were prepared by
bringing a drop of the dispersion onto a Formvar carbon-coated
microscope grid. The excess of the dispersion was removed by blot-
ting with a filter paper after 1 min, and the sample was shadowed
under an angle of 45° by evaporation of Pt. All samples were
studied with a Philips TEM201 microscope (60 kV).
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Monolayer Experiments: Monolayer experiments were performed
with a themostatted double barrier Riegler & Kirstein trough of
dimensions 6 3 25 cm with a compression speed of 7.0 cm2/min.
The film balance was housed in a Laminar Downflow cabinet (type
DLF 460, Clean air techniek, Woerden). The surface pressure was
measured using Wilhelmy plates and octadecanol was used for cal-
ibration. The surfactant was spread using a chloroform/methanol
(9:1, v/v) solution (ca. 10 ìL, 1 mg/ml); after 10 min, compression
was started.
UV and Circular Dichroism: The liposomal transfection agent N-
(2,3-dioleoyloxypropyl)-N,N,N-trimethylammonium methylsulfate
(dioleoyltrimethylammonium propane, DOTAP) was purchased
from Boehringer Mannheim. º-Phage DNA (Escherichia coli
W3110, strain ºc1857, Sam 7, 48502 base pairs) was purchased
from Sigma, cat. no. D9768. Absorption spectra were recorded by
using a Perkin2Elmer Lambda 6 UV/Vis spectrometer and CD
measurements were performed with a Jasco-600 spectropolari-
meter. The effects of additions of increasing amounts of the surfact-
ants on the CD spectra of º-phage DNA (43.3 ì, base molar, one
A260 unit is equivalent to 40 ìg of DNA) were monitored at 25 °C
in a 10 m PIPES (pH 5 7.0) buffer, and the spectral changes
were recorded after each addition (typically 10 ìL of the surfactant
dispersions, prepared as described in the electron microscopy sec-
tion).
Agarose Gel Electrophoresis:[7,8] The pCMV-luciferase plasmid
DNA used in the transfection experiments (see below) was incub-
ated with ethidium bromide (3,8-diamino-5-ethyl-6-phenylphen-
anthridium bromide) in water for 15 min at room temperature. Ge-
mini surfactants in water were then added in various concentrations
up to 1 mg/ml (total volume 20 ìL) and the mixture was incubated
for another 30 min at room temperature. After addition of a load-
ing buffer, the samples were subjected to electrophoresis at 75 V
(constant) on a 0.6% agarose gel in a 1x TBE (tris/borate/EDTA)
buffer system. After approx. 1.222 h, the gel run was stopped, and
the gel visualized with UV light. The loss of the ethidium bromide
fluorescence was taken as a measure of the capacity of the surfact-
ant to release the probe from the fluorescent complex with DNA.
Gene Transfection and Cytotoxicity:[7,8] The adherent cell line
CHO-K1[38] was used for all transfection measurements. Complete
medium consisted of MEM alpha medium supplemented with 10%
v/v foetal bovine serum and 1x -Glutamine. All media and supple-
ments, including the reference cytofectin LipofectAMINE PlusTM,
were obtained from Life Technologies. Stable transfected cell lines
expressing â-galactosidase were generated by cotransfection of the
plasmid pSV-â-Galactosidase Control Vector (Promega) with the
plasmid Selecta Vecta-Neo (R&D Systems) in a 10:1 ratio. Follow-
ing G418 (Life Technologies) selection (0.8 mg ml21), candidate
cell lines were tested for â-galactosidase activity (â-Gal Reporter
Gene Assay, chemiluminescent; Roche Diagnostics). Cells were
seeded into T25 flasks (Costar) 16218 h prior to transfection at an
approximate density of 7.5 3 105 cells per flask. For transfection,
5 ìg of the luciferase reporter gene plasmide, pGL3-Control vector
(Promega), was incubated with various concentrations of the
gemini surfactants in a final volume of 400 ìL. After 30 min of
incubation at room temperature, 2.6 mL of OPTI-MEMR medium
(Life Technologies) was added to the transfection mixture and the
solution placed on the cells. Following a 3 h or overnight incuba-
tion at 37 °C, the transfection solution was replaced with complete
medium and the cells incubated for a further 24 h at 37 °C. Cells
were then harvested and seeded into 96 well plates at a density of
0.5 3 105 cells per well and incubated at 37 °C for a further
16218 h. Control transfections were carried out using Lipofect-
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AMINE PlusTM (Life Technologies) according to the manufac-
turer’s guidelines. Reporter gene assays were performed according
to the manufacturer’s guidelines (Roche Diagnostics) approxim-
ately 48 h post transfection. Luminescence was measured in a Pack-
ard TopCount NXT Microplat Scintillation and Luminescence
Counter. Gene transfection activities were given on a scale from I
to V, where I means ‘‘not active’’ (, 1000 counts/s), II ‘‘weak’’
(1000210000 counts/s), III ‘‘active’’ (10000250000 counts/s),
IV ‘‘more active’’ (500002150000 counts/s), and V ‘‘very active’’
(. 150000 counts/s), corresponding to the activity of Lipofect-
AMINE PlusTM in this assay. For assessment of the cell toxicity
using flow cytometry, transfected CHO-KA cells were removed
from the wells used in the transfection experiments using 0.25%
trypsin solution (Life Technologies), supplemented with 2 ìg/ml
propidium iodide to label dead cells, and analysed with a Becton
Dickinson FACScan flow cytometer operated by CellQuest version
3.1F (Becton Dickinson).
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